RT Journal Article
SR Electronic
T1 Redefining the Bladder Cancer Phenotype using Patterns of Familial Risk
JF medRxiv
FD Cold Spring Harbor Laboratory Press
SP 19003681
DO 10.1101/19003681
A1 Hanson, Heidi A.
A1 Leiser, Claire L.
A1 Martin, Christopher
A1 Gupta, Sumati
A1 Smith, Ken R.
A1 Dechet, Christopher
A1 Lowrance, William
A1 O’Neil, Brock
A1 Camp, Nicola J.
YR 2019
UL http://medrxiv.org/content/early/2019/08/16/19003681.abstract
AB Relatives of bladder cancer (BCa) patients have been shown to be at increased risk for kidney, lung, thyroid, and cervical cancer after correcting for smoking related behaviors that may concentrate in some families. We demonstrate a new method to simultaneously assess risks for multiple cancers to identify distinct multi-cancer configurations (multiple different cancer types that cluster in relatives) surrounding BCa patients. We identified 6,416 individuals with urothelial carcinoma and familial information using the Utah Cancer Registry and Utah Population Database (UPDB). First-degree relatives, second-degree relatives, and first cousins were used to construct a familial enrichment matrix for cancer-types previously shown to be individually associated with BCa. K-medioids clustering were used to identify Familial Multi-Cancer Configurations (FMC). A case-control design and Cox regression with a 1:5 ratio of BCa cases to cancer-free controls was used to quantify the risk in specific relative-types and spouses in each FMC. Clustering analysis revealed 12 distinct FMCs, each exhibiting a different pattern of cancer co-aggregation. Of the 12 FMCs, four exhibited strong familial risk of bladder cancer along with specific patterns of increased risk of cancers in other sites (BCa FMCs), and were the focus of further investigation. Cancers at increased risk in these four BCa FMCs most commonly included melanoma, prostate and breast cancer and less commonly included leukemia, lung, pancreas and kidney cancer. A network-based approach can be used with familial data to discover new phenotype clusters for BCa, providing new directions for discovering patterns of cancer clustering.Competing Interest StatementThe authors have declared no competing interest.Funding StatementNational Institutes of Health K12 Award, 1K12HD085852-01; National Institutes of Health K07 Award 1K07CA230150-01, and HCI Cancer Center Support Grant (grant number P30CA042014).Author DeclarationsAll relevant ethical guidelines have been followed and any necessary IRB and/or ethics committee approvals have been obtained.YesAll necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.Not ApplicableAny clinical trials involved have been registered with an ICMJE-approved registry such as ClinicalTrials.gov and the trial ID is included in the manuscript.Not ApplicableI have followed all appropriate research reporting guidelines and uploaded the relevant Equator, ICMJE or other checklist(s) as supplementary files, if applicable.YesData for this study are not publicly available due to privacy restrictions.